Jin-Soo Song

Title: **Innovator Jin-Soo Song: Pioneering Humanized Antibody Research**

Introduction

Jin-Soo Song is a distinguished inventor based in Daejeon, South Korea, known for his contributions to the field of biotechnology. With a focus on humanized antibodies, his innovative work has led to valuable advancements in medical science.

Latest Patents

Jin-Soo Song holds a notable patent for a "Humanized antibody and process for preparing same." This patent describes a process for producing humanized antibodies by selecting specificity determining residues (SDR) from the complementarity determining region (CDR) of murine monoclonal antibody heavy and light chain variable regions. The method involves grafting the SDR to the corresponding amino acid sequences in human antibody variable regions, paving the way for improved therapeutic applications.

Career Highlights

Professionally, Jin-Soo Song is associated with Aprogen Inc., a leading biopharmaceutical company that focuses on developing high-quality antibody-based therapies. His role in the company underscores his commitment to advancing medical technology and improving patient care through innovative solutions.

Collaborations

Throughout his career, Jin-Soo has collaborated with esteemed colleagues, including Hyo Jeong Hong and Cheol-Young Maeng. These partnerships have helped foster a creative environment conducive to breakthroughs in antibody research and development.

Conclusion

Jin-Soo Song's contributions to the field of humanized antibodies exemplify the essence of innovation in biotechnology. His groundbreaking patent and collaborative efforts highlight the importance of teamwork and creativity in driving advancements that can significantly impact healthcare and therapeutic science.